Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Breast Cancer Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04491942
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more
National Cancer Institute (NCI) 74
Large-scale testing (Phase 3)Study completedNCT02253459
What this trial is testing

Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Beijing Biostar Pharmaceuticals Co., Ltd. 405
Testing effectiveness (Phase 2)Looking for participantsNCT06889610
What this trial is testing

A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.

Who this might be right for
Triple Negative Breast Cancer MetastaticMelanoma MetastaticColorectal Cancer Metastatic
Fudan University 95
Large-scale testing (Phase 3)Looking for participantsNCT06998108
What this trial is testing

Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine Therapy

Who this might be right for
HR+/HER2- Locally Advanced, Metastatic Breast Cancer
BeBetter Med Inc 330
Testing effectiveness (Phase 2)Looking for participantsNCT07610720
What this trial is testing

Dalpiciclib, Anti-HER2 Therapy, and Endocrine Therapy for Hormone-Receptor-Positive, HER2-Positive Metastatic Breast Cancer

Who this might be right for
Advanced/Metastatic Breast CancerHER2-Positive Metastatic Breast Cancer
Sun Yat-sen University 57
Not applicableStudy completedNCT01927081
What this trial is testing

Self-management Interventions for Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer Stage IV
Duke University 65
Testing effectiveness (Phase 2)Study completedNCT01656538
What this trial is testing

Reolysin For Patients With Advanced/Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Canadian Cancer Trials Group 81
Early research (Phase 1)Study completedNCT00005858
What this trial is testing

LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+3 more
University of Maryland, Baltimore 25
Early research (Phase 1)Ended earlyNCT00511576
What this trial is testing

Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors

Who this might be right for
Breast CancerLung CancerPulmonary Cancer+5 more
Mirati Therapeutics Inc. 54
Not applicableStudy completedNCT02023359
What this trial is testing

Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Novartis Healthcare A/S 7
Testing effectiveness (Phase 2)Study completedNCT01160718
What this trial is testing

Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
Swiss Cancer Institute 46
Large-scale testing (Phase 3)Study completedNCT00081796
What this trial is testing

Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer

Who this might be right for
Breast CancerMetastases
Sanofi 438
Early research (Phase 1)Study completedNCT00005023
What this trial is testing

Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer

Who this might be right for
Breast CancerLung CancerOvarian Cancer
University of Washington
Testing effectiveness (Phase 2)Study completedNCT01891227
What this trial is testing

Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer

Who this might be right for
Breast Cancer
Arbeitsgemeinschaft medikamentoese Tumortherapie 40
Testing effectiveness (Phase 2)Looking for participantsNCT06064812
What this trial is testing

A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.

Who this might be right for
Metastatic Breast CancerLocally Advanced Breast CancerBreast Cancer Stage IV+1 more
Forward Pharmaceuticals Co., Ltd. 99
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07340619
What this trial is testing

Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.

Who this might be right for
Metastatic (Stage IV) Melanoma
UNICANCER 51
Not applicableLooking for participantsNCT07347600
What this trial is testing

Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Locally Advanced Breast CancerMetastatic Breast Cancer
Hoffmann-La Roche 500
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Testing effectiveness (Phase 2)Active Not RecruitingNCT06590857
What this trial is testing

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

Who this might be right for
Metastatic Breast CancerHER2-negative Breast CancerER+ Breast Cancer+7 more
RayzeBio, Inc. 16
Large-scale testing (Phase 3)Study completedNCT00418028
What this trial is testing

Standard Versus Continuous Capecitabine in Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Hospital San Carlos, Madrid 195
Next Page